References
- Bennet W., Sundberg B., Lundgren T., Tibell A., Groth C.G., Richards A., White D.J., Elgue G., Larsson R., Nilsson B., Korsgren O. (2000). Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation, 69: 711-719.
- Brodbeck W.G., Kuttner - Kondo L., Mold C., Medof M.E. (2000). Structure/function studies of human decay-accelerating factor. Immunology, 101: 104-111.
- Bucher P., Morel P., Buhler L.H. (2005). Xenotransplantation: an update on recent progress and future perspectives. Transpl. Int., 18: 894-901.
- Costa C., Zhao L., Decesare S., Fodor W.L. (1999). Comparative analysis of three genetic modifications designed to inhibit human serum-mediated cytolysis. Xenotransplantation, 6: 6-16.
- Higgins P.J., Ko J.L., Lobell R., Sardonini C., Alessi M.K., Yeh C.G. (1997). A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities. J. Immunol., 158: 2872-2881.
- Hinchliffe S.J., Rushmere N.K., Hanna S.M., Morgan B.P. (1998). Molecular cloning and functional characterization of the pig analogue of CD59: relevance to xenotransplantation. J. Immunol., 160: 3924-3932.
- Huang J., Gou D., Zhen C., Jiang D., Mao X., Li W., Chen S., Cai C. (2001). Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP. FEMS Immunol. Med. Microbiol., 31: 203-209.
- Lipiński D., Duszewska A.M., Zeyland J., M a ły E., Gawron W., Rynkowska A., Reklewski Z., S łomski R. (2007). Obtaining transgenic bovine skin fibroblasts containing human interferon alpha. Anim. Sci. Pap. Rep., 25: 211-220.
- Lipiński D., Michalak E., S łomski R. (2006). DNA integration in animal transgenesis (in Polish). Med. Weter., 62: 992-997.
- Liu B., Cheng C., Wu Y., Wei J., Li G., Ma T. (2008). Transgenic mice designed to express human alpha-1,2-fucosyltransferase in combination of human DAF and CD59 to avoid xenograft rejection. Sci. China Ser. C, 51: 199-204.
- Michalak E., Kątska - Książkiewicz L., Kalak R., Lipiński D., Wielgus K., Jarmuż M., Szalata M., Ryńska B., Smorąg Z., Słomski R. (2004). In vitro transfection of fibroblasts and evaluation of transgenesis in long-term cell cultures. Ann. Anim. Sci., 4: 233-240.
- Nagahama M., Shiraishi M., Oshiro T., Taira K., Sugawa H., Nozato E., Nomura H., Nagamine M., Muto Y. (2002). Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells. Transpl. Int., 15: 205-211.
- Oliveira R.R., Carvalho D.M., Lisauskas S., Mello E., Vianna G.R., Dode M.A., Rumpf R., Aragao F.J., Rech E.L. (2005). Effectiveness of liposomes to transfect livestock fibroblasts. Genet. Mol. Res., 4: 185-196.
- Pertea M., Lin X., Salzberg S.L. (2001). GeneSplicer:anew computational method for splice site prediction. Nucleic Acids Res., 29: 1185-1190.
- Recillas - Targa F. (2006). Multiple strategies for gene transfer, expression, knockdown, and chromatin influence in mammalian cell lines and transgenic animals. Mol. Biotechnol., 34: 337-354.
- Tango M.J., Safaris E., Romanella M., Aminian A., Katerelos M., Somerwille C., Tearle R.G., Pearse M.J., D' Apice A.J.E. (1997). Additive effects of CD59 expression in Gal knockout mice in vitro but not in an ex vivo model. Xenotransplantation, 4: 25-33.
- Wasowska B.A., Lee C.Y., Halushka M.K., Baldwin W.M. 3rd. (2007). New concepts of complement in allorecognition and graft rejection. Cell Immunol., 248: 18-30.
- Wilson C.A. (2008). Porcine endogenous retroviruses and xenotransplantation. Cell Mol. Life Sci. 65: 3399-3341.
- Zhou C.Y., Mc Innes E., Copeman L., Langford G., Parsons N., Lancaster R., Richards A., Carrington C., Thompson S. (2005). Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor. Xenotransplantation, 12: 142-148.